期刊文献+

良性阵发性位置性眩晕再发的相关因素研究 被引量:2

Study on the related factors of recurrence of benign paroxysmal positional vertigo
原文传递
导出
摘要 良性阵发性位置性眩晕(BPPV)是一种临床常见的眩晕疾病,中老年人群高发。国内外研究发现BPPV患者经治疗后的再发率为7%~50%之间,且再发患者多合并相关共病,如高血压、糖尿病、骨质疏松症、偏头痛、前庭功能障碍等,可能导致BPPV反复发作。BPPV的反复发作会令患者焦虑不安,影响身心健康,使患者总体生活质量下降。本文将国内外与BPPV再发相关的研究进行归类总结,分析BPPV再发的危险因素以及临床意义。
作者 宋玉玉 张祎 刘博 Song Yuyu;Zhang Yi;Liu Bo(Department of Otorhinolaryngology Head and Neck Surgery,Beijing Tongren Hospital,Capital Medical University,Beijing Institute of Otolaryngology,Key Laboratory of Otorhinolaryngology Head and Neck(Capital Medical University),Ministry of Education,Beijing 100730,China)
出处 《国际耳鼻咽喉头颈外科杂志》 2021年第6期351-354,共4页 International Journal of Otolaryngology-Head and Neck Surgery
基金 北京市科委首都市民健康培育项目(Z151100003915100) 首都卫生科研发展专项(首发2016-3-1091) 首都医科大学附属北京同仁医院"重点医学发展计划"(trzdyxzy201802)。
  • 相关文献

参考文献3

二级参考文献37

  • 1Feig DI, Kang DH, Nakagawa T, Mazzali M, Johnson RJ. Uric acid and hypertension. Curr Hypertens Rep 2006; 8: 111-5.
  • 2Gertzberg N, Neumann P, Rizzo V, Johnson A. NAD(P)H oxidase mediates the endothelial barrier dysfunction induced by TNF-alpha. Am J Physiol Lung Cell Mol Physiol 2004; 286: L37-48.
  • 3Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, et al. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006; 8: 691-728.
  • 4Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38: 1101-6.
  • 5Watanabe S, Kang DH, Feng L, Nakagawa T, Kanellis J, Lan H, et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 2002; 40: 355-60.
  • 6Itoh H, Higuchi H, Hiraoka N, Ito M, Konishi T, Nakano T, et al. Contraction of rat thoracic aorta strips by endothelin-1 in the absence of extracellular Ca2+. Br J Pharmacol 1991; 104: 847-52.
  • 7Cai L, Kang YJ. Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc Toxicol 2001; 1: 181-93.
  • 8Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007; 293: C584-96.
  • 9Iglarz M, Schiffrin EL. Role of endothelin-1 in hypertension. Curr Hypertens Rep 2003; 5: 144-8.
  • 10Ergul A. Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents. Pharmacotherapy 2002; 22: 54-65.

共引文献64

同被引文献26

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部